Effects of neuropeptide Y (NPY) and [d-Trp32]NPY on monoamine and metabolite levels in dialysates from rat hypothalamus during feeding behavior

Neuropeptides ◽  
1996 ◽  
Vol 30 (4) ◽  
pp. 391-398 ◽  
Author(s):  
F.F Matos ◽  
V Guss ◽  
C Korpinen
1996 ◽  
Vol 271 (1) ◽  
pp. R217-R221 ◽  
Author(s):  
M. J. Glass ◽  
M. Grace ◽  
J. P. Cleary ◽  
C. J. Billington ◽  
A. S. Levine

Modulation of feeding behavior by neuropeptide Y (NPY) and opioids is well established, but the possibility that these neural influences provoke specific appetites, NPY for carbohydrate and opioids for fat, has also been considered. In other studies, intake of standard chow after NPY stimulation can be blocked by naloxone, indicating an interaction between these systems in the regulation of feeding. The present experiments examined the nature of NPY-opioid interactions in diet selection. Rats were administered NPY and naloxone concurrently, then chose between high-fat and high-carbohydrate diets. Subcutaneous administration of naloxone (0.01-0.3 mg/kg) potently reduced intake of the preferred diet, but not the nonpreferred diet. A similar pattern of selection was seen in a separate experiment where the same doses of naloxone were administered after 24-h food deprivation. These data support the idea that the opioid system mediates the “rewarding” aspects of feeding.


Gene Therapy ◽  
2004 ◽  
Vol 11 (9) ◽  
pp. 797-804 ◽  
Author(s):  
A J Noordmans ◽  
D K Song ◽  
C J Noordmans ◽  
M Garrity-Moses ◽  
M J During ◽  
...  

2006 ◽  
Vol 349 (3) ◽  
pp. 969-975 ◽  
Author(s):  
Jae Geun Kim ◽  
Il Seong Nam-Goong ◽  
Chang Ho Yun ◽  
Jin Kwon Jeong ◽  
Eun Sook Kim ◽  
...  

2008 ◽  
Vol 200 (1) ◽  
pp. 93-105 ◽  
Author(s):  
E Guillod-Maximin ◽  
A F Roy ◽  
C M Vacher ◽  
A Aubourg ◽  
V Bailleux ◽  
...  

Adiponectin is involved in the control of energy homeostasis in peripheral tissues through Adipor1 and Adipor2 receptors. An increasing amount of evidence suggests that this adipocyte-secreted hormone may also act at the hypothalamic level to control energy homeostasis. In the present study, we observed the gene and protein expressions of Adipor1 and Adipor2 in rat hypothalamus using different approaches. By immunohistochemistry, Adipor1 expression was ubiquitous in the rat brain. By contrast, Adipor2 expression was more limited to specific brain areas such as hypothalamus, cortex, and hippocampus. In arcuate and paraventricular hypothalamic nuclei, Adipor1, and Adipor2 were expressed by neurons and astrocytes. Furthermore, using transgenic green fluorescent protein mice, we showed that Adipor1 and Adipor2 were present in pro–opiomelanocortin (POMC) and neuropeptide Y (NPY) neurons in the arcuate nucleus. Finally, adiponectin treatment by intracerebroventricular injection induced AMP-activated protein kinase (AMPK) phosphorylation in the rat hypothalamus. This was confirmed byin vitrostudies using hypothalamic membrane fractions. In conclusion, Adipor1 and Adipor2 are both expressed by neurons (including POMC and NPY neurons) and astrocytes in the rat hypothalamic nuclei. Adiponectin is able to increase AMPK phosphorylation in the rat hypothalamus. These data reinforced a potential role of adiponectin and its hypothalamic receptors in the control of energy homeostasis.


Sign in / Sign up

Export Citation Format

Share Document